Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer

Quality of Life in CKD Patients Treated With Erythropoiesis-Stimulating Agents

Hepcidin: clinical utility as a diagnostic tool and therapeutic target

A Comparison of Aerobic Exercise and Resistance Training in Patients With and Without Chronic Kidney Disease

Evolution of Treatment for Anemia in Chronic Kidney Disease

Complications of Progression of CKD

Critical Missing Data on Erythropoiesis-Stimulating Agents in CKD: First Beat Placebo

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD

Quality of Life and Depression in CKD: Improving Hope and Health

Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort

Update in Critical Care for the Nephrologist: Transfusion in Nonhemorrhaging Critically Ill Patients

Bone Marrow Iron in CKD: Correlation With Functional Iron Deficiency

Phytate and Kidney Health: The Roles of Dietary Phytate in Inhibiting Intestinal Phosphorus Absorption and Intravenous Phytate in Decreasing Soft Tissue Calcification

Nutrition interventions to address cardiovascular outcomes in chronic kidney disease

What are the causes of protein-energy malnutrition in chronic renal insufficiency?

Overview of renal bone disease: Causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach: Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease